Can anyone confirm PTD's share of HUMIRA / ABBOTT? See below from CBS newsflash.
"Abbott Laboratories shares climbed after the Food and Drug Administration approved its Humira rheumatoid arthritis drug. The product may boost the company's revenue by $150 million this year, Morgan Stanley estimates."